The AFteR Registry - Follow-up Study to Monitor the Efficacy and Safety of the Occlutech AFR in Heart Failure Patients

NCT04405583 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2026-01-29

No results posted yet for this study

Summary

This study aims to monitor the safety and efficacy of Occlutech AFR device in patients with Heart Failure.

Conditions

Interventions

DEVICE

Occlutech Atrial Flow Regulator

The Occlutech Atrial Flow Regulator is an interatrial shunt device for transcatheter delivery.

Sponsors & Collaborators

  • Occlutech International AB

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-28
Primary Completion
2027-06-30
Completion
2027-10-31

Countries

  • France
  • Germany
  • Greece
  • Italy
  • Portugal
  • Serbia
  • Tunisia
  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04405583 on ClinicalTrials.gov